BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6247214)

  • 61. Failure of opiates to reverse dopamine inhibition of prolactin secretion in vitro.
    Login IS; Macleod RM
    Eur J Pharmacol; 1979 Dec; 60(2-3):253-5. PubMed ID: 527660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Secretion of growth hormone, prolactin, ACTH and testosterone after blockade of opiate receptors during stress in humans and rats].
    Vigas M; Jurcovicová J; Jezová D; Tatár P
    Bratisl Lek Listy; 1986 Jul; 86(1):3-13. PubMed ID: 3015361
    [No Abstract]   [Full Text] [Related]  

  • 63. Release of prolactin in response to microinjection of morphine into mesencephalic dorsal raphe nucleus.
    Johnson JH
    Neuroendocrinology; 1982; 35(3):169-72. PubMed ID: 6290924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis.
    Iversen LL; Iversen SD; Bloom FE
    Nature; 1980 Mar; 284(5754):350-1. PubMed ID: 6244503
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Opiate and dopamine receptors in the isolated nictitating membrane of the cat.
    Illés P; Knoll J
    Pol J Pharmacol Pharm; 1978; 30(2-3):293-304. PubMed ID: 209424
    [No Abstract]   [Full Text] [Related]  

  • 66. Interaction of opiates with dopamine receptors: receptor binding and behavioral assays.
    Carlson KR; Seeger TF
    Pharmacol Biochem Behav; 1982 Jan; 16(1):119-24. PubMed ID: 6173883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of local micro injections of opiates and enkephalins into the forebrain on the electrocorticogram of the rat.
    Neal H; Keane PE
    Electroencephalogr Clin Neurophysiol; 1978 Nov; 45(5):655-65. PubMed ID: 81768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Studies on the accessibility of prolactin and growth hormone to brain: effect of opiate agonists on hormone levels in serial, simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey.
    Belchetz PE; Ridley RM; Baker HF
    Brain Res; 1982 May; 239(1):310-4. PubMed ID: 7093687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of the hypothalamus in opiate-stimulated prolactin secretion.
    Dobson PR; Brown BL
    Regul Pept; 1988 Apr; 20(4):305-10. PubMed ID: 3368581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of opioids on central thermoregulatory mechanisms.
    Clark WG
    Pharmacol Biochem Behav; 1979 Apr; 10(4):609-13. PubMed ID: 223174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Naltrexone blocks nicotine-induced prolactin release.
    Flores CM; Hulihan-Giblin BA; Kellar KJ
    Neuropharmacology; 1989 Nov; 28(11):1287-90. PubMed ID: 2594167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1976 Sep; 58(1):101-7. PubMed ID: 974367
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells.
    Chang A; Shin SH
    Eur J Endocrinol; 1999 Oct; 141(4):387-95. PubMed ID: 10526254
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kappa opioid receptors of human placental villi modulate acetylcholine release.
    Ahmed MS; Schoof T; Zhou DH; Quarles C
    Life Sci; 1989; 45(25):2383-93. PubMed ID: 2558265
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Failure of naloxone to reverse apomorphine effects in humans.
    Rowbotham MC; Joseph MS; Jones RT; Keil LC
    Psychoneuroendocrinology; 1983; 8(1):95-102. PubMed ID: 6308702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endogenous opiates block dopamine inhibition of prolactin secretion in vitro.
    Enjalbert A; Ruberg M; Arancibia S; Priam M; Kordon C
    Nature; 1979 Aug; 280(5723):595-7. PubMed ID: 223069
    [No Abstract]   [Full Text] [Related]  

  • 80. Interaction of opiate peptides with dopamine effects on prolactin secretion and membrane electrical properties in anterior pituitary cells from lactating rats.
    Enjalbert A; Israel JM; Zhang J; Kordon C; Vincent JD
    J Neuroendocrinol; 1990 Dec; 2(6):807-13. PubMed ID: 19215423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.